Induced pluripotent stem cell-derived MYH11 c.4599+1G>A vascular smooth muscle cells display a synthetic phenotype compared to non-carrier controls and offer a platform for therapeutic gene therapy

17 April 2026 (08:30 - 18:00)
Organised by: Logo
Congress Presentation Part of: Poster session (1) Vascular Diseases Delegates Premium Access Frontiers in CardioVascular Biomedicine 2026 Council on Basic Cardiovascular Science

ESC 365 is supported by

ESC 365 is supported by